Shareholder alert: pomerantz law firm investigates claims on behalf of investors of y-mabs therapeutics, inc. - ymab

New york, new york--(newsfile corp. - february 2, 2023) - pomerantz llp is investigating claims on behalf of investors of y-mabs therapeutics, inc. ("y-mabs" or the "company") (nasdaq: ymab). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.the investigation concerns whether y-mabs and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
YMAB Ratings Summary
YMAB Quant Ranking